These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30040030)

  • 1. Cannabinoids for the treatment of behavioral and psychological symptoms of dementia.
    Tampi RR; Young JJ; Tampi DJ
    Neurodegener Dis Manag; 2018 Aug; 8(4):211-213. PubMed ID: 30040030
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.
    Hill MN; Campolongo P; Yehuda R; Patel S
    Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting modern cannabinoid pharmacology for therapeutic gain?
    Ritter JM
    Br J Clin Pharmacol; 2012 May; 73(5):671-3. PubMed ID: 22486598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cannabis and cannabinoids as drugs].
    Khiabani HZ; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.
    Ranieri R; Marasco D; Bifulco M; Malfitano AM
    Recent Pat CNS Drug Discov; 2016; 10(2):157-177. PubMed ID: 27184693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease.
    Little JP; Villanueva EB; Klegeris A
    Mini Rev Med Chem; 2011 Jun; 11(7):582-90. PubMed ID: 21699489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and Pain: Weeding Out Undesired Effects With a Novel Approach to Analgesia.
    De Aquino JP; Ross DA
    Biol Psychiatry; 2018 Nov; 84(10):e67-e69. PubMed ID: 30360776
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of cannabinoids.
    Grotenhermen F
    Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
    Fitzpatrick JK; Downer EJ
    Neuropharmacology; 2017 Feb; 113(Pt B):618-626. PubMed ID: 27079840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Cannabinoids in Treating Dementia.
    Weier M; Hall W
    Curr Neurol Neurosci Rep; 2017 Aug; 17(8):56. PubMed ID: 28631194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacology of the endocannabinoids: far beyond anandamide.
    Pamplona FA; Takahashi RN
    J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia.
    Sherman C; Ruthirakuhan M; Vieira D; Lanctôt KL; Herrmann N
    Curr Opin Psychiatry; 2018 Mar; 31(2):140-146. PubMed ID: 29256923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant, synthetic, and endogenous cannabinoids in medicine.
    Di Marzo V; Petrocellis LD
    Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?
    Lienau FS; Füllgraf H; Moser A; Feuerstein TJ
    Eur J Neurol; 2007 Oct; 14(10):1162-9. PubMed ID: 17880571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids biology: the search for new therapeutic targets.
    Felder CC; Dickason-Chesterfield AK; Moore SA
    Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings.
    Gustafsson M; Sandman PO; Karlsson S; Gustafson Y; Lövheim H
    Int Psychogeriatr; 2013 Sep; 25(9):1415-23. PubMed ID: 23782794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoids and psychopathology: the therapy inside.
    Drago F
    Pharmacol Res; 2007 Nov; 56(5):357-9. PubMed ID: 17942319
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabinoids and Postcardiac Surgery: Preclinical Insights Pave the Way for Future Research.
    Martinez Naya N; Denicolai M; Kelly J; Toldo S
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):531-533. PubMed ID: 38579326
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.
    Gustafsson M; Isaksson U; Karlsson S; Sandman PO; Lövheim H
    Eur J Clin Pharmacol; 2016 Aug; 72(8):987-94. PubMed ID: 27071994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.